Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Eigelberger

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Endocrinology and Metabolism Clinics of North America|October 18, 2000
Surgical approaches to primary hyperparathyroidismM S Eigelberger, O H Clark
Current Treatment Options in Oncology|June 12, 2002
PheochromocytomaM S Eigelberger, Q Y Duh
Surgery|December 14, 2001
Phenylacetate enhances the antiproliferative effect of retinoic acid in follicular thyroid cancerM S Eigelberger, M G Wong, Q Y Duh, et al.
Surgery|December 15, 2000
Neutralizing vascular endothelial growth factor activity inhibits thyroid cancer growth in vivoE Y Soh, M S Eigelberger, K J Kim, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Endocrinology and Metabolism Clinics of North America|October 18, 2000
Surgical approaches to primary hyperparathyroidismM S Eigelberger, O H Clark
Current Treatment Options in Oncology|June 12, 2002
PheochromocytomaM S Eigelberger, Q Y Duh
Surgery|December 14, 2001
Phenylacetate enhances the antiproliferative effect of retinoic acid in follicular thyroid cancerM S Eigelberger, M G Wong, Q Y Duh, et al.
Surgery|December 15, 2000
Neutralizing vascular endothelial growth factor activity inhibits thyroid cancer growth in vivoE Y Soh, M S Eigelberger, K J Kim, et al.
Pageof 1